North America Onychomycosis (Tinea Unguium) Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview

• 1.1 Onychomycosis (Tinea Unguium) Drug Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Oral
  • 1.2.2 External
• 1.3 Market Analysis by Applications
  • 1.3.1 Age under 18
  • 1.3.2 Age 18-50
  • 1.3.3 Age above 50
• 1.4 Market Analysis by Countries
  • 1.4.1 United States Status and Prospect (2013-2023)
  • 1.4.2 Mexico Status and Prospect (2013-2023)
  • 1.4.3 Canada Status and Prospect (2013-2023)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Johnson & Johnson
  • 2.1.1 Business Overview
  • 2.1.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    • 2.1.2.1 Type 1
    • 2.1.2.2 Type 2
  • 2.1.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.2 GSK
  • 2.2.1 Business Overview
  • 2.2.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    • 2.2.2.1 Type 1
    • 2.2.2.2 Type 2
  • 2.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.3 Novartis
  • 2.3.1 Business Overview
  • 2.3.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    • 2.3.2.1 Type 1
    • 2.3.2.2 Type 2
  • 2.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.4 Pfizer
  • 2.4.1 Business Overview
  • 2.4.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    • 2.4.2.1 Type 1
    • 2.4.2.2 Type 2
  • 2.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.5 Valeant Pharma
  • 2.5.1 Business Overview
  • 2.5.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    • 2.5.2.1 Type 1
    • 2.5.2.2 Type 2
  • 2.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.6 Kaken Pharmaceutical
  • 2.6.1 Business Overview
  • 2.6.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    • 2.6.2.1 Type 1
    • 2.6.2.2 Type 2
  • 2.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.7 Galderma
  • 2.7.1 Business Overview
  • 2.7.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    • 2.7.2.1 Type 1
    • 2.7.2.2 Type 2
  • 2.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.8 Xiuzheng Pharmaceutical
  • 2.8.1 Business Overview
  • 2.8.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    • 2.8.2.1 Type 1
    • 2.8.2.2 Type 2
  • 2.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.9 Letai
  • 2.9.1 Business Overview
  • 2.9.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    • 2.9.2.1 Type 1
    • 2.9.2.2 Type 2
  • 2.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.10 Qilu Pharmaceutical
  • 2.10.1 Business Overview
  • 2.10.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    • 2.10.2.1 Type 1
    • 2.10.2.2 Type 2
  • 2.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 North America Onychomycosis (Tinea Unguium) Drug Market Competition, by Manufacturer

• 3.1 North America Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)
  • 3.1.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)
  • 3.1.2 North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer (2016-2017)
• 3.2 North America Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)
  • 3.2.1 North America Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)
  • 3.2.2 North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer (2016-2017)
• 3.3 North America Onychomycosis (Tinea Unguium) Drug Price by Manufacturers (2016-2017)
• 3.4 Market Concentration Rate
  • 3.4.1 Top 3 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share (2016-2017)
  • 3.4.2 Top 5 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share (2016-2017)
• 3.5 Market Competition Trend

4 North America Onychomycosis (Tinea Unguium) Drug Market Analysis by Countries

• 4.1 North America Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Countries (2013-2018)
  • 4.1.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Countries (2013-2018)
  • 4.1.2 North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2013-2018)
• 4.2 North America Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Market Share by Countries (2013-2018)
  • 4.2.1 North America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
  • 4.2.2 North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)

5 North America Market Segmentation Onychomycosis (Tinea Unguium) Drug by Type

• 5.1 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2013-2018)
  • 5.1.1 North America Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)
  • 5.1.2 North America Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2013-2018)
• 5.2 Type 1 Sales Growth Rate and Price
• 5.2 Oral Sales Growth and Price
  • 5.2.1 North America Oral Sales Growth (2013-2018)
  • 5.2.2 North America Oral Price (2013-2018)
• 5.3 External Sales Growth and Price
  • 5.3.1 North America External Sales Growth (2013-2018)
  • 5.3.2 North America External Price (2013-2018)

6 North America Market Segmentation Onychomycosis (Tinea Unguium) Drug by Application

• 6.1 North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)
• 6.2 Age under 18 Sales Growth (2013-2018)
• 6.3 Age 18-50 Sales Growth (2013-2018)
• 6.4 Age above 50 Sales Growth (2013-2018)

7 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

• 7.1 United States Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)
• 7.2 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type
  • 7.2.1 United States Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)
  • 7.2.2 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)
• 7.3 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2013-2018)
  • 7.3.1 United States Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)
  • 7.3.2 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)
• 7.4 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)
  • 7.4.1 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)
  • 7.4.2 United States Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)
• 7.5 United States Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

8 Canada Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

• 8.1 Canada Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)
• 8.2 Canada Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)
  • 8.2.1 Canada Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)
  • 8.2.2 Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)
• 8.3 Canada Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2013-2018)
  • 8.3.1 Canada Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)
  • 8.3.2 Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)
• 8.4 Canada Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)
  • 8.4.1 Canada Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)
  • 8.4.2 Canada Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)
• 8.5 Canada Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

9 Mexico Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

• 9.1 Mexico Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)
• 9.2 Mexico Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)
  • 9.2.1 Mexico Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)
  • 9.2.2 Mexico Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)
• 9.3 Mexico Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2013-2018)
  • 9.3.1 Mexico Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)
  • 9.3.2 Mexico Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)
• 9.4 Mexico Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)
  • 9.4.1 Mexico Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)
  • 9.4.2 Mexico Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)
• 9.5 Mexico Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

10 Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)

• 10.1 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2018-2023)
• 10.2 Onychomycosis (Tinea Unguium) Drug Market Forecast by Countries (2018-2023)
  • 10.2.1 North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Countries (2018-2023)
  • 10.2.2 United States Onychomycosis (Tinea Unguium) Drug Forecast (2018-2023)
  • 10.2.3 Canada Onychomycosis (Tinea Unguium) Drug Forecast (2018-2023)
  • 10.2.4 Mexico Onychomycosis (Tinea Unguium) Drug Forecast (2018-2023)
• 10.3 Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2018-2023)
  • 10.3.1 North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2018-2023)
  • 10.3.2 North America Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2018-2023)
• 10.4 Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2018-2023)
  • 10.4.1 North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2018-2023)
  • 10.4.2 North America Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2018-2023)

11 Onychomycosis (Tinea Unguium) Drug Manufacturing Cost Analysis

• 11.1 Onychomycosis (Tinea Unguium) Drug Key Raw Materials Analysis
  • 11.1.1 Key Raw Materials
  • 11.1.2 Price Trend of Key Raw Materials
  • 11.1.3 Key Suppliers of Raw Materials
  • 11.1.4 Market Concentration Rate of Raw Materials
• 11.2 Proportion of Manufacturing Cost Structure
  • 11.2.1 Raw Materials
  • 11.2.2 Labor Cost
  • 11.2.3 Manufacturing Expenses
• 11.3 Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

• 12.1 Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
• 12.2 Upstream Raw Materials Sourcing
• 12.3 Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Manufacturers in 2017
• 12.4 Downstream Buyers

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology